2nd Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Firm
Client
Income
$196,425
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: S. 355 (119th), H.R. 4273 (119th), H.R. 2821 (119th), H.R. 3686 (119th), H.R. 1 (119th)

Pharmacy PHA

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1219 (119th)

Manufacturing MAN

- Pharmaceutical Tariffs

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: White House Office; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.